Episode Details
Back to Episodes
Bundibugyo Ebola Vaccine Race
Description
Ebola’s rare Bundibugyo strain is sparking global alarm, with over 1,000 suspected cases and nearly 250 deaths in the DRC, plus 9 confirmed in Uganda. Without a dedicated vaccine, experts fear it could match or exceed the 2014-2016 West Africa outbreak. But hope is rising: IAVI, Moderna, and Oxford are racing to develop vaccines using cutting-edge tech—IAVI’s adapted Zaire vaccine showed 100% protection in monkeys, Moderna’s mRNA platform, and Oxford’s pandemic-tested tech—all funded by CEPI, with Oxford aiming for trials in 2-3 months. These vaccines train immune systems to recognize the virus, offering a crucial defense against this deadly, unpredictable outbreak.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/fbd1ae651fd8bb3c